A detailed history of Nicolet Bankshares Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nicolet Bankshares Inc holds 21,552 shares of BMY stock, worth $1.19 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
21,552
Previous 22,940 6.05%
Holding current value
$1.19 Million
Previous $1.24 Million 28.05%
% of portfolio
0.19%
Previous 0.26%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $55,867 - $73,550
-1,388 Reduced 6.05%
21,552 $895,000
Q1 2024

May 09, 2024

BUY
$47.98 - $54.4 $28,212 - $31,987
588 Added 2.63%
22,940 $1.24 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $25,306 - $30,197
522 Added 2.39%
22,352 $1.15 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $305,080 - $341,127
-5,270 Reduced 19.45%
21,830 $1.27 Million
Q2 2023

Aug 09, 2023

BUY
$63.71 - $70.74 $264,651 - $293,853
4,154 Added 18.1%
27,100 $1.73 Million
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $19,121 - $21,688
-291 Reduced 1.25%
22,946 $1.59 Million
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $78,683 - $93,172
1,149 Added 5.2%
23,237 $1.67 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $141 - $83,448
-1,086 Reduced 4.69%
22,088 $1.57 Million
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $10,457 - $11,517
144 Added 0.63%
23,174 $1.78 Million
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $51,274 - $61,482
834 Added 3.76%
23,030 $1.68 Million
Q4 2021

Feb 09, 2022

BUY
$53.63 - $62.52 $31,105 - $36,261
580 Added 2.68%
22,196 $1.38 Million
Q3 2021

Nov 16, 2021

BUY
$59.17 - $69.31 $75,737 - $88,716
1,280 Added 6.29%
21,616 $1.28 Million
Q2 2021

Aug 11, 2021

BUY
$61.91 - $67.42 $55,780 - $60,745
901 Added 4.64%
20,336 $1.36 Million
Q1 2021

May 03, 2021

BUY
$59.34 - $66.74 $111,677 - $125,604
1,882 Added 10.72%
19,435 $1.23 Million
Q4 2020

Feb 02, 2021

BUY
$57.74 - $65.43 $2,887 - $3,271
50 Added 0.29%
17,553 $1.09 Million
Q2 2020

Jul 22, 2020

SELL
$54.82 - $64.09 $19,187 - $22,431
-350 Reduced 1.96%
17,503 $1.03 Million
Q1 2020

Apr 22, 2020

BUY
$46.4 - $67.43 $51,643 - $75,049
1,113 Added 6.65%
17,853 $995,000
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $23,522 - $30,682
478 Added 2.94%
16,740 $1.08 Million
Q3 2019

Oct 22, 2019

SELL
$42.77 - $50.71 $1,197 - $1,419
-28 Reduced 0.17%
16,262 $825,000
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $42,790 - $47,317
959 Added 6.26%
16,290 $739,000
Q1 2019

Apr 26, 2019

SELL
$45.12 - $53.8 $21,116 - $25,178
-468 Reduced 2.96%
15,331 $731,000
Q4 2018

Feb 06, 2019

SELL
$48.76 - $63.23 $78,016 - $101,168
-1,600 Reduced 9.2%
15,799 $821,000
Q3 2018

Oct 29, 2018

SELL
$55.19 - $62.25 $9,106 - $10,271
-165 Reduced 0.94%
17,399 $1.08 Million
Q2 2018

Jul 31, 2018

SELL
$50.53 - $62.98 $19,403 - $24,184
-384 Reduced 2.14%
17,564 $972,000
Q4 2017

Feb 02, 2018

SELL
$59.94 - $65.35 $54,305 - $59,207
-906 Reduced 4.81%
17,948 $1.1 Million
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $1.04 Million - $1.2 Million
18,854
18,854 $1.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Nicolet Bankshares Inc Portfolio

Follow Nicolet Bankshares Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Bankshares Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Bankshares Inc with notifications on news.